IGC PHARMA, INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount
IGC PHARMA, INC. (IGC) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount of $0 for the 12-month period ending 2019-03-31, per its 10-K filed 2019-06-14.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther · last filed 2019-06-14
- IGC PHARMA, INC. effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2019 was $0.00.
- IGC PHARMA, INC. effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2018 was $0.00.
- IGC PHARMA, INC. effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2017 was $0.00.
- IGC PHARMA, INC. effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2016 was $0.00.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount 12 month |
|---|---|
| 2019-03-31 | $0.00 10-K · filed 2019-06-14 |
| 2018-03-31 | $0.00 10-K · filed 2019-06-14 |
| 2017-03-31 | $0.00 10-K · filed 2018-06-21 |
| 2016-03-31 | $0.00 10-K · filed 2017-07-14 |
| 2015-03-31 | $0.00 10-K · filed 2016-07-14 |
| 2014-03-31 | $0.00 10-K · filed 2015-07-14 |
| 2013-03-31 | $0.00 10-K · filed 2014-07-15 |
| 2012-03-31 | $406.05K 10-K · filed 2014-07-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |